Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Atezolizumab, Obinutuzumab, and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Relapsed or Refractory Richter Syndrome

M.D. Anderson Cancer Center · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
chronic lymphocytic leukemia, recurrent transformed chronic lymphocytic leukemia, refractory transformed chronic lymphocytic leukemia, richter syndrome, small lymphocytic lymphoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 805322
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.